GlassScriptPhysician profile
Quadrell T Conerly
NPI 1659922284
$3,310.36
in general payments reported to CMS, 2019-2025
21 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $2,330 · 2023: $92.91 · 2024: $195 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,243.88 | 2021-2024 | Intellis Adaptivestim, Venaseal |
| Spinal Simplicity, LLC | $879.62 | 2022 | |
| Boston Scientific Corporation | $234.19 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management, Infinion 16 |
| Collegium Pharmaceutical, INC. | $215.05 | 2021-2025 | Belbuca, Xtampza |
| Abbvie INC. | $189.31 | 2021-2025 | |
| Allergan, INC. | $66.29 | 2021-2022 | |
| Lilly USA, LLC | $60.05 | 2021-2022 | |
| Eisai INC. | $46.11 | 2022 | |
| Azurity Pharmaceuticals, INC. | $44.96 | 2024 | Horizant |
| Amgen INC. | $41.60 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $40.95 | 2021 | |
| Vertos Medical, INC. | $37.19 | 2022 | |
| Scilex Pharmaceuticals INC. | $35.00 | 2022-2025 | |
| Tactile Systems Technology INC | $29.99 | 2021 | |
| Leo Pharma INC. | $24.58 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $23.53 | 2022 | |
| Nevro Corp. | $22.34 | 2024 | Senza |
| Averitas Pharma INC. | $21.78 | 2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $21.50 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.12 | 2022 | |
| Sebela Pharmaceuticals INC. | $14.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quadrell Conerly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.